The medications include Abbott Laboratories Inc's Lupron, AstraZeneca Plc's Zoladex, Watson Pharmaceuticals Inc's Trelstar, and Sanofi-Aventis SA's Eligard.
Thursday, October 21, 2010
FDA orders new warnings on prostate cancer drugs
FDA orders new warnings on prostate cancer drugs: "WASHINGTON (Reuters) - Certain hormone treatments for prostate cancer must carry new warnings about an increased risk of diabetes and heart problems, the U.S. Food and Drug Administration said on Wednesday.
The medications include Abbott Laboratories Inc's Lupron, AstraZeneca Plc's Zoladex, Watson Pharmaceuticals Inc's Trelstar, and Sanofi-Aventis SA's Eligard.
"
The medications include Abbott Laboratories Inc's Lupron, AstraZeneca Plc's Zoladex, Watson Pharmaceuticals Inc's Trelstar, and Sanofi-Aventis SA's Eligard.
Baldness drug works, but some have sexual problems
Baldness drug works, but some have sexual problems: "NEW YORK (Reuters Health) - The widely used baldness drug finasteride (Propecia) indeed boosts hair growth in men, but some may develop sexual problems, according to a new analysis.
A review of recent research found that men with the most common form of baldness who took finasteride are more likely to experience an increase in hair count, and say they believe their hair is thicker. But approximately 1 in 80 also experience erectile dysfunction
"
A review of recent research found that men with the most common form of baldness who took finasteride are more likely to experience an increase in hair count, and say they believe their hair is thicker. But approximately 1 in 80 also experience erectile dysfunction
Wednesday, October 20, 2010
Men with prostate cancer at higher colon cancer risk: study (AFP)
Men with prostate cancer at higher colon cancer risk: study
(AFP): "
AFP - Men who have prostate cancer have a higher risk of developing colon cancer than men who don't have prostate cancer, US researchers said Tuesday.
Pomakov stressed the importance of men who have been diagnosed with prostate cancer having routine screening for colon cancer and called for larger studies to be done to determine if screening for colorectal cancer should begin earlier for prostate cancer patients than the currently recommended age of 50.
"
(AFP): "
AFP - Men who have prostate cancer have a higher risk of developing colon cancer than men who don't have prostate cancer, US researchers said Tuesday.Pomakov stressed the importance of men who have been diagnosed with prostate cancer having routine screening for colon cancer and called for larger studies to be done to determine if screening for colorectal cancer should begin earlier for prostate cancer patients than the currently recommended age of 50.
"
Subscribe to:
Posts (Atom)